Cite Filings / PHAT / 0001415889-25-012779

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Phathom Pharmaceuticals, Inc. Filed 2025-05-13 Acc 0001415889-25-012779

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-08-20 SCHEDULE 13D/A Beneficial Ownership Report
2025-05-15 4 Director bought 7,420 shares at an average $3.30 ($24,462)
2025-05-13 SCHEDULE 13D/A Beneficial Ownership Report
2025-05-13 4 Director bought 48,203 shares at an average $3.17 ($152,917)
2025-05-08 4 Director bought 10,000 shares at an average $2.50 ($24,985)
2025-05-06 3 Initial Statement of Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…